GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

COCH · Jun 30, 2026

Envoy Medical, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001213900-26-086974General Corporate
Operating cash generation9thOwn-history percentile · N=11
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-10698.04% · OPTIONAL · VALID

Revenue growth0thOwn-history percentile · N=8
Evidence method

Yoy · gp.fundamentals.revenue

-34.62% · CORE · VALID

Inventory pressure73thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

3096.08% · OPTIONAL · VALID

Gross margin0thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.gross_margin

-445.10% · CORE · VALID

Operating margin27thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.operating_margin

-10919.61% · CORE · VALID

R&D intensity82thOwn-history percentile · N=11
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

6141.18% · OPTIONAL · VALID

SBC intensity80thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

419.61% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History13 statesHistory building
Sep 30, 20230/5 normalizedLevel 3Sep 30, 20230/6 normalizedAmended as filedDec 31, 20230/7 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20250/8 normalizedLevel 3Sep 30, 20255/8 normalizedLevel 3Dec 31, 20256/8 normalizedLevel 3Mar 31, 20265/6 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 3
Period transition

What moved in the state?

Cash Generation Increased
Previous
-15541.03%
Current
-10698.04%
Delta
4842.99%
Growth Decreased
Previous
-15.22%
Current
-34.62%
Delta
-19.40%
Inventory Pressure Decreased
Previous
3820.51%
Current
3096.08%
Delta
-724.43%
Profitability Increased
Previous
-15279.49%
Current
-10919.61%
Delta
4359.88%
R And D Intensity Decreased
Previous
9338.46%
Current
6141.18%
Delta
-3197.28%
Sbc Intensity Decreased
Previous
612.82%
Current
419.61%
Delta
-193.21%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Compared To · Orthopedic, Prosthetic & Surgical Appliances & Supplies peers →Transitioned To · COCH Fundamental State →Transitioned To · COCH CASH_GENERATION_INCREASED →Transitioned To · COCH GROWTH_DECREASED →Transitioned To · COCH INVENTORY_PRESSURE_DECREASED →Transitioned To · COCH PROFITABILITY_INCREASED →Transitioned To · COCH R_AND_D_INTENSITY_DECREASED →Transitioned To · COCH SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.